DE602005011667D1 - Proteinallergenderivate - Google Patents

Proteinallergenderivate

Info

Publication number
DE602005011667D1
DE602005011667D1 DE602005011667T DE602005011667T DE602005011667D1 DE 602005011667 D1 DE602005011667 D1 DE 602005011667D1 DE 602005011667 T DE602005011667 T DE 602005011667T DE 602005011667 T DE602005011667 T DE 602005011667T DE 602005011667 D1 DE602005011667 D1 DE 602005011667D1
Authority
DE
Germany
Prior art keywords
protein allergen
allergenic activity
wild
derivatives
type protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005011667T
Other languages
German (de)
English (en)
Inventor
Kerstin Westritschnig
Margarete Focke
Peter Valent
Walter Keller
Rudolf Valenta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomay AG
Original Assignee
Biomay AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36202602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005011667(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomay AG filed Critical Biomay AG
Publication of DE602005011667D1 publication Critical patent/DE602005011667D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602005011667T 2004-12-02 2005-12-02 Proteinallergenderivate Expired - Lifetime DE602005011667D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0202804A AT501101B1 (de) 2004-12-02 2004-12-02 Protein-allergen-derivat
PCT/AT2005/000486 WO2006058359A2 (en) 2004-12-02 2005-12-02 Protein allergen derivatives

Publications (1)

Publication Number Publication Date
DE602005011667D1 true DE602005011667D1 (de) 2009-01-22

Family

ID=36202602

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005011667T Expired - Lifetime DE602005011667D1 (de) 2004-12-02 2005-12-02 Proteinallergenderivate

Country Status (11)

Country Link
US (1) US20080286311A1 (enExample)
EP (1) EP1817330B1 (enExample)
JP (1) JP2008521837A (enExample)
CN (1) CN101068830B (enExample)
AT (2) AT501101B1 (enExample)
AU (1) AU2005312324B2 (enExample)
CA (1) CA2589187A1 (enExample)
DE (1) DE602005011667D1 (enExample)
ES (1) ES2319218T3 (enExample)
PL (1) PL1817330T3 (enExample)
WO (1) WO2006058359A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709435B2 (en) 2003-01-21 2014-04-29 Biomay Ag Hypallergenic mosaic antigens and methods of making same
ES2307381B1 (es) * 2006-04-12 2009-10-23 Bial Industrial Farmaceutica S.A. Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
ES2638308T3 (es) * 2008-03-25 2017-10-19 Bial Industrial Farmaceutica, S.A. Proteínas híbridas hipoalergénicas de alérgenos de ácaros del grupo 1 y 2 principales para uso en el tratamiento de alergias
EP2110383A1 (en) 2008-04-14 2009-10-21 Biomay AG Hypoallergenic variants
EP2295076A1 (en) 2009-09-10 2011-03-16 Biomay Ag Hypoallergenic hybrid polypeptides for the treatment of allergy
CA2870399A1 (en) * 2012-04-16 2013-10-24 Alk-Abello A/S Plant profilin polypeptides for use in non-specific allergy immunotherapy
CN110055340B (zh) * 2019-04-11 2021-01-01 中国农业大学 一种食品中牛源成分快速检测方法及试剂盒
CN113173982B (zh) * 2021-04-14 2022-09-06 中国海洋大学 Rap v 2蛋白相关的抗原表位肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0765936A1 (en) * 1987-06-17 1997-04-02 Institute For Child Health Research Cloning of mite allergens
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
CA2066801A1 (en) * 1991-04-26 1992-10-27 Shyam S Mohapatra Determination of dna sequences of a novel group of major grass pollen allergens and the synthesis of their correspsonding recombinant proteins
JPH1075783A (ja) * 1996-09-04 1998-03-24 Fumakilla Ltd 組換えダニアレルゲン
JP2001231563A (ja) * 2000-02-18 2001-08-28 Asahi Breweries Ltd 改変したダニアレルゲン（システイン変異体）及びその製造方法
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US7279295B2 (en) * 2002-03-27 2007-10-09 Phadia Ab Allergen
PT1403280E (pt) * 2002-09-27 2005-11-30 Biomay Prod & Handel Vacinas hipoalergenicas baseadas no alergenio ph1 p 7 de polen de capim timoteo
WO2004039834A2 (en) * 2002-11-01 2004-05-13 Alk-Abelló A/S Recombinant protein variants
DE60301944T2 (de) * 2003-01-21 2006-06-01 Biomay Produktions- Und Handels-Aktiengesellschaft Verfahren zur Vorbereitung von hypoallergenen Mosaikproteinen#

Also Published As

Publication number Publication date
PL1817330T3 (pl) 2009-06-30
WO2006058359A2 (en) 2006-06-08
ATE417060T1 (de) 2008-12-15
AT501101A1 (de) 2006-06-15
ES2319218T3 (es) 2009-05-05
CA2589187A1 (en) 2006-06-08
AU2005312324B2 (en) 2011-05-12
WO2006058359A3 (en) 2006-07-27
CN101068830B (zh) 2012-05-09
CN101068830A (zh) 2007-11-07
EP1817330A2 (en) 2007-08-15
AT501101B1 (de) 2008-01-15
EP1817330B1 (en) 2008-12-10
AU2005312324A1 (en) 2006-06-08
JP2008521837A (ja) 2008-06-26
US20080286311A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
WO2005063820A3 (en) Il-7 fusion proteins
EA200700917A1 (ru) Способ рефолдинга рекомбинантных антител
WO2012054929A3 (en) Use of human serum albumin to decrease antigenicity of therapeutic proteins
WO2011009058A3 (en) Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
MY163480A (en) Sclerostin binding agents
WO2006119467A3 (en) Protein activity modification
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
WO2007095506A8 (en) Oligosaccharide modification and labeling of proteins
ATE489465T1 (de) Gezielte integration in die ppp1r12c-position
SG149000A1 (en) Gag binding proteins
NO20070699L (no) Spesielle aminoalkylglukosaminidfosfatforbindelser og deres anvendelse
EA200701377A1 (ru) Имплантируемый биоматериал и способ его получения
EA200900492A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
WO2008123999A3 (en) Anti-ige antibodies
WO2007001264A3 (en) Method of making recombinant human antibodies for use in biosensor technology
NO20091181L (no) Anti-C5AR-antistoffer med forbedrede egenskaper
ATE417060T1 (de) Proteinallergenderivate
EP1930428A4 (en) HEFEWIRT, TRANSFORMANTE AND PROCESS FOR PREPARING FOREIGN PROTEIN
EP1969127B8 (en) Method of producing biologically active vitamin k dependent proteins by recombinant methods
WO2006106348A3 (en) Protein glycosylation
WO2006125201A3 (en) Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
WO2005086654A3 (en) Self-cleaving affinity tags and methods of use
TW200626073A (en) Activated globular protein and its use in edible compositions
WO2008015419A3 (en) Protein solubilisation
EP2436765A3 (en) Recombinant factor X with no glycosylation and method for preparing the same

Legal Events

Date Code Title Description
8363 Opposition against the patent